Immunogenicity 13143
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
OLIG2
Transcript ID
uc021wil.1
HLA INFO
B*27:02
TCR INFO
No TCR info found!
Full length protein sequence (323 aa)
MDSDA
1
SLVSS
6
RPSSP
11
EPDDL
16
FLPAR
21
SKGSS
26
GSAFT
31
GGTVS
36
SSTPS
41
DCPPE
46
LSAEL
51
RGAMG
56
SAGAH
61
PGDKL
66
GGSGF
71
KSSSS
76
STSSS
81
TSSAA
86
ASSTK
91
KDKKQ
96
MTEPE
101
LQQLR
106
LKINS
111
RERKR
116
MHDLN
121
IAMDG
126
LREVM
131
PYAHG
136
PSVRK
141
LSKIA
146
TLLLA
151
RNYIL
156
MLTNS
161
LEEMK
166
RLVSE
171
IYGGH
176
HAGFH
181
PSACG
186
GLAHS
191
APLPA
196
ATAHP
201
AAAAH
206
AAHHP
211
AVHHP
216
ILPPA
221
AAAAA
226
AAAAA
231
AAVSS
236
ASLPG
241
SGLPS
246
VGSIR
251
PPHGL
256
LKSPS
261
AAAAA
266
PLGGG
271
GGGSG
276
ASGGF
281
QHWGG
286
MPCPC
291
SMCQV
296
PPPHH
301
HVSAM
306
GAGSL
311
PRLTS
316
DAK
321
Mutation Information
DNA mutation:
None
Peptide Range:
85 ~ 109
Mut AA position:
97 (13 in Wild Type peptide)
Alignment
Wild Type:
"STSSAAASSTKKDKKQMTEPELQQL
||||||||||||.||||||||||||
Mutant:
STSSAAASSTKKGKKQMTEPELQQL"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) OLIG2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay